Netflix blames its content slate, regional price increases and a "pull-forward effect" of its strong Q1 growth for the miss.Technologyread more
Netflix lost paid U.S. subscribers for the first time in eight years and fell below analyst estimates for international subscriber growth.Tech Driversread more
Despite a disappointing earnings report, Wall Street analysts are sticking by the stock and looking ahead to the third quarter.Marketsread more
Treasury Secretary Steven Mnuchin says if the call goes well, he would expect in-person meetings to take place.Marketsread more
Revenue of $10.24 billion exceeded the consensus estimate by almost $250 million.Financeread more
The strengthening of the president's formidable campaign war chest has led his organization, along with the Republican National Committee, to raise over $100 million in the...2020 Electionsread more
The three-judge panel in the U.S. Court of Appeals for the Second Circut also upheld the more than $7.7 million in fines and restitution that a judge imposed on Shkreli last...Biotech and Pharmaceuticalsread more
Raymond James upgraded Apple and said its most recent checks show Apple is preparing to bring a 5G iPhone to a wider range of models than previously thought.Marketsread more
Toys R Us is opening two permanent stores in November — at Simon Property Group's Galleria mall in Houston and at Unibail-Rodamco-Westfield's Garden State Plaza mall in...Retailread more
Philip Morris International beats second-quarter earnings and revenue estimates and hikes its full-year forecast as its new tobacco products gain momentum.Health and Scienceread more
Billionaire hedge fund manager Ray Dalio just picked gold as a prime long-term opportunity. Here's why one market watcher says he could be wrong.Trading Nationread more
Many people would probably be surprised to know that Israel has become synonymous with marijuana over the years because of research conducted by its top scientists and professors. Now a group in New York state wants to bring the best of that know-how to America.
Dr. Raphael Mechoulam, now a professor at the Hebrew University of Jerusalem, was the first person to isolate the psychoactive THC component of marijuana. He was also the first to test THC drops in children with cancer. And some of the major advances Mechoulam made in his cannabis research were financially sponsored by the American government in the form of the National Institute of Health (NIH) grants long before marijuana was medicinally legal in the United States.
"The NIH gave me grant money and I was lucky enough to get money for almost forty years. I got about $150,00 per year, multiply that by forty, it's quite a bit," Mechoulam told CNBC last year.
"They [NIH] said it was in the American interest to support our work."
Now that partnership is expanding as Tikun Olam, the major research institution that works with the Israeli government on medical marijuana, has announced that it plans to come to the U.S. next week to create a program that would share medical marijuana data with American health experts. The organization is hoping to get a medical marijuana license in New York by partnering with the Compassionate Care Center of New York, and the program directors say the financial incentive could be huge.
Aharon Lutzky, CEO Tikun Olam, told CNBC that his institution has the largest patient database in the world, and that they have monitored, "each patient's ailment and the efficacy of the different strain variations and dosages used for each patient," for almost a decade.
"We hope to create a partnership between Israel, Canada and the U.S. for the benefit of all New York patients, and to provide the state Department of Health with the benefit of everything Israel has learned from the years of trial and error, " Lutzky said.
The Compassionate Care Center of New York (CCCNY) has exclusive licenses for two out of the three strains of medical marijuana that have high CBD and low THC levels. CBD is another component of marijuana that has been shown in many studies to have medicinal effects, but without many of the side effects of THC.
CCCNY CEO Dr. Larry Good told CNBC that getting a registration is a time consuming and difficult process, so the partnership with his organization is necessary for Tikkun Olam to bring all of its marijuana data and expertise to America.
The question is whether New York will let any of it happen. Almost half the states in America have legalized the use of medical marijuana, but New York is just starting the process of licensing medical marijuana operations after just legalizing it earlier this year. Economic concerns should quicken the approval process, if the folks in Albany are paying attention. According to Arcview Group, a cannabis investment fund that tracks industry numbers, the legal market for both recreational and medical marijuana nationwide will be $3.5 billion this year.